Clinical research trials find new homes in emerging markets

Several factors have contributed to an 8.3% year-on-year growth in the global pharma market. Some of these are a flurry of M&A’s, demand for generic drugs in emerging countries, patent expiration giving impetus to the generic drug industry etc. While these factors have brought about immense opportunities globally, the path to harness these is laden with challenges.

Sample this - New entrants who wish to take advantage of expired patents, new drug research and development often need to conduct clinical trials to gain regulatory approval. Naturally, these trials considerably increase the cost of drug R&D. In such a case, is it viable to venture into the market?

A recently concluded research study by UBM TechWeb and Wipro shows a clear trend emerging to combat this – conducting clinical trials in emerging markets. A majority of the study respondents said that they have either ventured into or have plans of conducting trials in emerging markets. The usual quartet comprising China, Brazil, India and Russia feature prominently on the destination list. South American countries like Venezuela and Argentina are new names that have been listed.

While this trend has several logistic, economic and social considerations, it could very well prove to be a vehicle of expansion for several companies. What has been your experience? Would be interesting to see views from everyone…

About the Author

Rajeshwar D Mitra (RD) has been with Wipro for the last 5 years. In his earlier roles in EAS, RD managed the SAP global alliance and was responsible for Wipro being chosen as a Global services partner of SAP. Thereafter he led the Supply chain practices in EAS and was responsible for driving significant value added growth. Prior to joining Wipro, RD has had over 16 years consulting and technology in organizations such as PricewaterhouseCoopers and IBM Business Consulting Services along with an entrepreneurial stint.

Service Offerings

Service Offerings

Client Themes

Client Themes

Clinical research trials

find new homes in

emerging markets

About the Author

Service Offerings

Industries

Cloud

Cybersecurity

Digital

EngineeringNXT

Holmes

Contact Us

About Wipro

Careers

Location

Leadership

Investors

Innovation

News and Events

Insights

Analyst Speak

Products & Platforms

Partner Ecosystem

Sustainability

Contact Wipro